Primary CNS lymphoma
C Grommes, LM DeAngelis - Journal of Clinical Oncology, 2017 - ascopubs.org
Primary CNS lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma that is
typically confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic …
typically confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic …
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
AJM Ferreri, M Reni, M Foppoli, M Martelli… - The Lancet, 2009 - thelancet.com
Background Chemotherapy with high-dose methotrexate is the conventional approach to
treat primary CNS lymphomas, but superiority of polychemotherapy compared with high …
treat primary CNS lymphomas, but superiority of polychemotherapy compared with high …
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma
C Grommes, JL Rubenstein, LM DeAngelis… - Neuro …, 2019 - academic.oup.com
Primary central nervous system lymphoma (PCNSL) is a rare form of non-Hodgkin
lymphoma that affects the brain parenchyma, spinal cord, eyes, and cerebrospinal fluid …
lymphoma that affects the brain parenchyma, spinal cord, eyes, and cerebrospinal fluid …
Diagnosis and management of primary central nervous system lymphoma
CH Han, TT Batchelor - Cancer, 2017 - Wiley Online Library
Primary central nervous system lymphoma (PCNSL) is a rare and aggressive extranodal
non‐Hodgkin lymphoma (NHL) that is confined to the brain, eyes, spinal cord, or …
non‐Hodgkin lymphoma (NHL) that is confined to the brain, eyes, spinal cord, or …
Diagnosis and treatment of primary CNS lymphoma
A Korfel, U Schlegel - Nature Reviews Neurology, 2013 - nature.com
Primary CNS lymphoma (PCNSL) is a rare lymphoma that is confined to the CNS, with low
tendency for systemic dissemination and a relatively aggressive course. Outcome in patients …
tendency for systemic dissemination and a relatively aggressive course. Outcome in patients …
How I treat primary CNS lymphoma
AJM Ferreri - Blood, The Journal of the American Society of …, 2011 - ashpublications.org
Primary CNS lymphoma (PCNSL) is a rare malignancy with peculiar clinical and biologic
features, aggressive course, and unsatisfactory outcome. It represents a challenge for …
features, aggressive course, and unsatisfactory outcome. It represents a challenge for …
How I treat CNS lymphomas
JL Rubenstein, NK Gupta, GN Mannis… - Blood, The Journal …, 2013 - ashpublications.org
The pathogenesis of primary and secondary central nervous system (CNS) lymphoma poses
a unique set of diagnostic, prognostic, and therapeutic challenges. During the past 10 years …
a unique set of diagnostic, prognostic, and therapeutic challenges. During the past 10 years …
Phase II trial of temsirolimus for relapsed/refractory primary CNS lymphoma
A Korfel, U Schlegel, U Herrlinger… - Journal of Clinical …, 2016 - ascopubs.org
Purpose In this phase II study (NCT00942747), temsirolimus was tested in patients with
relapsed or refractory primary CNS lymphoma (PCNSL). Patients and Methods …
relapsed or refractory primary CNS lymphoma (PCNSL). Patients and Methods …
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma
M Deckert, A Engert, W Brück, AJM Ferreri, J Finke… - Leukemia, 2011 - nature.com
Recent studies addressing the molecular characteristics of PCNSL, which is defined as
malignant B-cell lymphoma with morphological features of DLBCL, have significantly …
malignant B-cell lymphoma with morphological features of DLBCL, have significantly …